JPRN-UMIN000011325已完成2 期
Phase II study of Pemetrexed + Carboplatin as first line therapy for nonsquamous non-small cell lung cancer with interstitial pneumonia - Phase II study of Pemetrexed + Carboplatin for lung cancer with interstitial pneumonia
Central Japan Lung Study Group (CJLSG)0 个研究点目标入组 25 人开始时间: 2013年7月31日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Having uncontroled infection 2) Having a fever (more than 38 degrees (Celsius)) 3) Having past history of acute exacerbation of interstitial pneumonia 4) Progression of interstitial pneumonia on chest CT within 3 months 5) Over 21mg/day dose of predonisolone 6) Sarcoidosis and collagen vascular diseases 7) Having past history of drug-induced lung injury and radiation pnumonitis 8) Having severe complications 9) Active concomitant malignancy without evidence of recurrence within 5 years 10) Having an uncontrolable pleural effusion 11) Having allergy for pemetrexed or carboplatin 12) History of pregnancy or lactation 13) Decision of ineligibility by the attending physician
研究者
相似试验
已完成
2 期
Phase 2 study of Pemetrexed + Carboplatin as first line therapy for non-squamous non-small cell lung cancer without EGFR Mutation (CJLSG0906)JPRN-UMIN000003393Central Japan Lung Study Group53
已完成
2 期
Phase 2 study of Pemetrexed + Carboplatin as first line therapy for non-squamous non-small cell lung cancer with EGFR Mutation (CJLSG0907)JPRN-UMIN000003394Central Japan Lung Study Group23
已完成
2 期
A Phase II study of Pemetrexed plus Carboplatin followed by maintenance Pemetrexed in patients with previously untreated stage III/IV or post-operative recurrent non-squamous non-small-cell and lung cancer.on-squamous non-small cell lung cancerJPRN-UMIN000003755Dept. of Respiratory Medicine, Osaka University Hospital40
已完成
2 期
Phase II study of Pemetrexed and Carboplatin plus Bevacizumab for advanced non-small cell lung cancernon-squamous non-small-cell lung cancerJPRN-UMIN000003680ippon Medical School Hospital26
招募中
2 期
A Phase II study of Pemetrexed plus Carboplatin Plus Bevacizumab followed by maintenance Pemetrexed in patients with previously untreated stage III/IV or non-squamous non-small-cell and lung cancer.on-squamous non-small cell lung cancer (EGFR mutation status Negative)JPRN-UMIN000005991Toho University Omori Medical Center35